Replicable Results in ME/CFS? Yes, Finally.
It’s a turning point researchers wait years, even decades, for: results that replicate. In our latest “What’s New in ME/CFS?” interview, Dr. Peter Rowe of Johns Hopkins University Medical School […]
Celiac Plexus Blocks Improve Long Covid–Associated Gastrointestinal Symptoms
Dr. Deborah Duricka is a professor at the University of Alaska; researcher at Neuroversion; and 2022 Solve Ramsay Grant Program awardee. In a new case report, Dr. Duricka described how […]
“What’s New in ME/CFS?” A New Series from Solve M.E.
As we move through the holiday season, many of us are reflecting on the year – the moments of difficulty, the small steps forward, and the quiet persistence it takes […]
Solve Urges Congress to Pass the FY2026 Defense Appropriations Act
As part of our ongoing coalition work, Solve M.E. joined over 157 organizations in urging Congress to pass a fully funded FY2026 Defense Appropriations Act. This annual bill includes the […]
Solve-Funded Study Finds Posture and Sex Affect Cardiometabolic Health in People with ME/CFS
Dr. Francisco Westermeier is an ME/CFS researcher at the FH JOANNEUM University of Applied Sciences (Austria) and a 2019 Solve Ramsay Grant Awardee. He specializes in how ME/CFS disease affects […]
Honoring the Vital Role of Caregivers in the ME/CFS and Long Covid Community
November is National Family Caregivers Month. It is a time to recognize and honor the millions of family caregivers who provide critical, ongoing support to loved ones facing chronic illness. […]
Hyperstimulated Innate Immune System Can Drive ME/CFS-Associated Fatigue and Post-Exertional Malaise
Dr. Ian Lipkin is a renowned professor of epidemiology, neurology, and pathology and director of the Center for Infection and Immunity at Columbia University. He has long been a leader […]
Register Today for “From Mystery to Measurable: The Science Behind the New ME/CFS Blood Test”
For the first time, scientists have developed a simple, accurate blood test that can potentially identify Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) — a long-term, debilitating condition that affects […]
Speak Up to Protect Access to an Emerging ME/CFS Treatment
Thank you to Patient Advocate & Researcher Deborah Duricka, PhD, for the below toolkit. Full toolkit here: https://solvecfs.org/wp-content/uploads/2025/10/Patients_Allies_Multi-MAC_LCD_Comment_Packet.pdf “Please add your voice to preserve access to chronic pain treatments involving […]
Simmaron’s Solve ME/CFS Catalyst Award-Winning Rapamycin Trial Yields Promising Treatment Findings
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a non-profit organization dedicated to understanding ME/CFS and related diseases and to treating people with these diseases. […]
The Unified Platform Now Open to Pediatric Participants
In August, we announced Solve M.E., in partnership with The Brain Inflammation Collaborative (BIC), the launch of the unhide® Solve Together Unified Platform, a digital health tool designed to uncover […]
Unique Blood-based Test Holds Much Promise for Diagnosing People with ME/CFS
Dr. Dmitri Pchejetski, a researcher at the University of East Anglia Medical School (United Kingdom), has developed a new blood-based assay, the EpiSwitch CFS test, that may prove very effective […]
